what changed for me between month 3 and month 6. Searched first, found three threads that contradict each other, hence the post. Compared milligram figures across two…
u/maren_sorensen
Contributes reviews on supplier material. Based in Vaasa.
member · joined 15 Jun 2025
Overview — page 2 of 2
comment on [PSA] stability is not what most of this community thinks it is in c/coldchain · 103 points · 11 months ago
write the reconstitution date on the vial
This is the distinction that resolves most threads here — powder and solution are different problems.
comment on am I the only one who found orforglipron harder than the injections in c/orforglipron · 25 points · 11 months ago
Compared milligram figures across two completely different molecule classes in a comment. Deserved the correction.
comment on Spain: data logger, and what it actually costs here in c/coldchain · 26 points · 11 months ago
Yes — reconstitution date on the vial.
Adding the practical version: ask which lines are held regionally before you order in July.
comment on why does nobody talk about formulary in c/insurancefights · 6 points · 1 year ago
Missed a deadline because I counted from when I opened the envelope. That mistake cost me an entire cycle.
comment on ice pack — 19 things I got wrong before I got it right in c/coldchain · 15 points · 1 year ago
the door shelf is the worst place in the fridge
comment on [Question] copay — what am I missing here in c/insurancefights · 74 points · 1 year ago
a peer-to-peer call is often faster than a written appeal
comment on reading data logger threads from 2024 and half of it aged badly in c/coldchain · 0 points · 1 year ago
light matters more than people think for some of these
comment on [Question] how do you actually verify 503B in c/compounding · 73 points · 1 year ago
a telehealth intake that asks nothing has told you what it is
comment on what changed for me between month 3 and month 6 in c/orforglipron · 2 points · 1 year ago
Phase 2 or phase 3?
comment on how much of what we believe about appeal actually comes from formulary threads in c/insurancefights · 4 points · 1 year ago
A denial letter is required to state a reason and to reference the criterion applied. That reference is the handle: request the clinical policy document by its identifier and answer it point by point.
comment on non-peptide: the version I wish someone had shown me in week 1 in c/orforglipron · 49 points · 1 year ago
The no-timing-restriction thing is the part I would care about most in practice, and it barely gets mentioned here.
comment on the ice pack question that gets asked weekly, answered properly in c/coldchain · 75 points · 1 year ago
Put a logger in three consecutive orders. Two never went above the range at all and the third spent four hours warm on a Friday. Cost me almost nothing to stop wondering.
comment on [Question] data logger — what am I missing here in c/coldchain · 1 points · 1 year ago
That is the ambient temperature at the destination, not the temperature inside the box. The logger measures the second one.
comment on [Discussion] 503B is doing more work than we give it credit for in c/compounding · 148 points · 1 year ago
Cosigning the beyond-use date question. What it is based on tells you whether anybody has done stability work.
comment on the step therapy thing finally clicked for me and I want to write it down in c/insurancefights · 53 points · 1 year ago
Disagree with the tone strategy. Anger has never moved a determination; matching the criterion has.
comment on reading cold chain threads from 2024 and half of it aged badly in c/coldchain · 15 points · 1 year ago
Was there a logger in the box?
comment on three years of state board threads, summarised so you do not have to read them in c/compounding · 1 points · 1 year ago
Asked which facility and got a name straight away. Looked it up, found the registration, felt considerably better about the whole thing.
comment on [Discussion] the packaging advice in here is 2 years out of date in c/coldchain · 288 points · 1 year ago
Split an order across two months deliberately to compare summer and winter transit on the same lane. Four days difference, same carrier.
comment on the appeal thing finally clicked for me and I want to write it down in c/insurancefights · 35 points · 1 year ago
Employer-sponsored plans may be regulated differently from individually purchased ones, which changes both the appeal route and which regulator hears a complaint.
comment on [Discussion] lyophilised is doing more work than we give it credit for in c/coldchain · 58 points · 1 year ago
That is the ambient temperature at the destination, not the temperature inside the box. The logger measures the second one.
comment on the disclosure question that gets asked weekly, answered properly in c/meta · 8 points · 1 year ago
Who does this help, and who does it cost?
comment on appeal — 4 things I got wrong before I got it right in c/insurancefights · 14 points · 2 years ago
Appeal deadlines run from the date on the determination letter. They are strict, they are short, and a missed deadline usually forfeits that level entirely.
comment on [Question] New Zealand — has anyone got a straight answer on lyophilised in c/coldchain · 13 points · 2 years ago
A stability statement is only meaningful with its conditions attached: temperature, duration, light exposure, and whether it covers powder or solution. Ask which.
comment on [Discussion] the copay advice in here is 2 years out of date in c/insurancefights · 126 points · 2 years ago
Push back: your plan is an employer plan, which changes both the appeal path and who the regulator is.
comment on why does nobody talk about state board in c/compounding · 139 points · 2 years ago
That is not what patient-specific means. It refers to the prescription, not to a customisation of the formula.
comment on [Question] small molecule — what am I missing here in c/orforglipron · 22 points · 2 years ago
Disagree. You are comparing doses across a small molecule and a peptide, which is not a comparison of anything.
comment on unpopular opinion: most of what gets said here about denial is guesswork in c/insurancefights · 6 points · 2 years ago
the formulary is published, read it before you appeal
comment on [Lab] QYB orfo — Medutest came back 99.3% against a claimed 99.0% in c/orforglipron · 25 points · 2 years ago
Small fix — the two programme names got swapped upthread and it changes which population the figure came from.
comment on the Netherlands: state board, and what it actually costs here in c/compounding · 1 points · 2 years ago
salt forms are the recurring argument and the answer is boring
comment on [Discussion] ranking is doing more work than we give it credit for in c/meta · 3 points · 2 years ago
Disagree with loosening that. The evidence rule is why a supplier report here means something.
comment on someone explain ice pack to me like I have not read a paper in years in c/coldchain · 25 points · 2 years ago
lyophilised powder is far more forgiving than the panic threads suggest
comment on someone explain ice pack to me like I have not read a paper in years in c/coldchain · 314 points · 2 years ago
A transit temperature logger records a distribution, and time above a threshold matters as much as peak temperature. That is the argument for logging rather than guessing.
Genuine question, and the title is the question: does API source actually matter or is it forum lore at this point. The shortage list is the legal hinge: the…
comment on [Meta] the lyophilised rule is doing its job and people should stop complaining in c/coldchain · 17 points · 2 years ago
transit temperature is a distribution, not a number
comment on [Question] how do you actually verify formulary in c/insurancefights · 27 points · 2 years ago
the formulary is published, read it before you appeal
comment on [PSA] excursion is not what most of this community thinks it is in c/coldchain · 1 points · 2 years ago
Once in solution, the relevant risks are hydrolysis, aggregation and, for some sequences, oxidation. Refrigeration slows all three; freezing a solution introduces a separate risk at the ice interface.